Literature DB >> 363259

Cancer of the pancreas: diagnostic accuracy and survival statistics.

B Gudjonsson, E M Livstone, H M Spiro.   

Abstract

We have reviewed the natural history, reliability of diagnosis, and survivorship of 100 patients with adenocarcinoma of the pancreas, in the context of a thorough review of the literature on survival after therapy for adenocarcinoma of the pancreas. There is 40--62.5% error in the histologic confirmation of the diagnosis of pancreatic cancer. The error by inspection and palpation alone at the time of surgery may be as great as 25%. The absolute 5 year survival rate calculated from 61 clinical studies representing approximately 15,000 patients is 0.4%. The best series in the current literature has only 3% 5 year rate based upon the total population of pancreatic cancer patients. 12.3% of 5 year survivors from the world literature did not have curative surgery. This study shows the necessity for standardization of reporting methods. The same patients and survivors should not be used repeatedly in different reports. Some authors who claim the most effective palliation by pancreatic resection have the highest mortality rates.

Entities:  

Mesh:

Year:  1978        PMID: 363259     DOI: 10.1002/1097-0142(197811)42:5<2494::aid-cncr2820420554>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  37 in total

Review 1.  Percutaneous biopsy of pancreatic lesions.

Authors:  J Neuerburg; R W Günther
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jan-Feb       Impact factor: 2.740

2.  Intraoperative ultrasonography in pancreatic cancer.

Authors:  G Serio; C Fugazzola; C Iacono; I A Bergamo Andreis; A Portuese; M Zicari; S Dall'Oglio; M Trivisone; A Dagradi
Journal:  Int J Pancreatol       Date:  1992-02

Review 3.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

Review 4.  Surgery for pancreatic cancer.

Authors:  D C Carter
Journal:  Br Med J       Date:  1980-03-15

5.  Cancer of the pancreas: palliative operation, Whipple procedure, or total pancreatectomy.

Authors:  W P Longmire
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

6.  Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Authors:  K Akhilender Naidu; Richard C Karl; Kamatham A Naidu; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

7.  Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Klöppel vs TNM grading.

Authors:  P C Giulianotti; U Boggi; G Fornaciari; J Bruno; G Rossi; D Giardino; G Di Candio; F Mosca
Journal:  Int J Pancreatol       Date:  1995-06

8.  Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients.

Authors:  J P Lerut; P R Gianello; J B Otte; P J Kestens
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

Review 9.  Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Authors:  Bryce Taylor
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

10.  Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis.

Authors:  Bernardo H L Goulart; Jeffrey W Clark; Gregory Y Lauwers; David P Ryan; Nina Grenon; Alona Muzikansky; Andrew X Zhu
Journal:  J Hematol Oncol       Date:  2009-03-16       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.